PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ovid Therapeutics

Ovid Therapeutics Entered into an Exclusive License Agreement with AstraZeneca to Expand its Epilepsy Franchise with Novel KCC2 Activators

Ovid Therapeutics Entered into an Exclusive License Agreement with AstraZeneca to Expand its Epilepsy Franchise with Novel KCC2 Ac...

January 3, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us